(Q38232105)

31 August 2017

Type I and type II Fc receptors regulate innate and adaptive immunity (English)

1 reference

31 August 2017

Rony Dahan

6

0 references

Jeffrey Ravetch

series ordinal

8

object named as

Jeffrey V Ravetch

1 reference

31 August 2017

5

Taia T Wang

1 reference

31 August 2017

2

Stylianos Bournazos

1 reference

31 August 2017

3

David J DiLillo

1 reference

31 August 2017

Andrew Pincetic

1

1 reference

31 August 2017

Jad Maamary

series ordinal

4

1 reference

31 August 2017

Benjamin-Maximillian Fiebiger

series ordinal

7

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 August 2014

1 reference

31 August 2017

1 reference

31 August 2017

15

1 reference

31 August 2017

707-716

1 reference

31 August 2017

8

1 reference

Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity

31 August 2017

1 reference

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

21 January 2018

1 reference

Fcgamma receptors as regulators of immune responses

21 January 2018

1 reference

Antibody-mediated modulation of immune responses.

21 January 2018

1 reference

A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs.

21 January 2018

1 reference

Functional and clinical consequences of Fc receptor polymorphic and copy number variants.

21 January 2018

1 reference

General mechanism for modulating immunoglobulin effector function

21 January 2018

1 reference

Fc-receptors as regulators of immunity.

21 January 2018

1 reference

21 January 2018

1 reference

FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

21 January 2018

1 reference

Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity

21 January 2018

1 reference

Fc receptors and their role in immune regulation and autoimmunity

21 January 2018

1 reference

Isotype and glycoform selection for antibody therapeutics

21 January 2018

1 reference

Analysis of the antibody structure based on high-resolution crystallographic studies

21 January 2018

1 reference

Divergent immunoglobulin g subclass activity through selective Fc receptor binding

21 January 2018

1 reference

Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity

21 January 2018

1 reference

IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface

21 January 2018

1 reference

Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha

21 January 2018

1 reference

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex

21 January 2018

1 reference

Structural Determinants of Unique Properties of Human IgG4-Fc

21 January 2018

1 reference

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.

21 January 2018

1 reference

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

21 January 2018

1 reference

Impact of differential glycosylation on IgG activity

21 January 2018

1 reference

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity

21 January 2018

1 reference

Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid

21 January 2018

1 reference

Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study

21 January 2018

1 reference

Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose

21 January 2018

1 reference

Revisiting the role of glycosylation in the structure of human IgG Fc.

21 January 2018

1 reference

In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner

21 January 2018

1 reference

Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides

21 January 2018

1 reference

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

21 January 2018

1 reference

Identification of a receptor required for the anti-inflammatory activity of IVIG.

21 January 2018

1 reference

T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies.

21 January 2018

1 reference

Crystal structure of IgE bound to its B-cell receptor CD23 reveals a mechanism of reciprocal allosteric inhibition with high affinity receptor Fc RI

21 January 2018

1 reference

Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination

21 January 2018

1 reference

Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs.

21 January 2018

1 reference

IgG2a-mediated enhancement of antibody responses is dependent on FcRgamma+ bone marrow-derived cells.

21 January 2018

1 reference

Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells

21 January 2018

1 reference

Selective suppression of interleukin-12 induction after macrophage receptor ligation

21 January 2018

1 reference

Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions

21 January 2018

1 reference

Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells

21 January 2018

1 reference

Inhibitory ITAMs as novel regulators of immunity.

21 January 2018

1 reference

Phagocytosis: elegant complexity

21 January 2018

1 reference

The coordination of signaling during Fc receptor-mediated phagocytosis

21 January 2018

1 reference

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

21 January 2018

1 reference

Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells

21 January 2018

1 reference

Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine

21 January 2018

1 reference

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

The function of Fcγ receptors in dendritic cells and macrophages

21 January 2018

1 reference

21 January 2018

1 reference

The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice

21 January 2018

1 reference

Follicular dendritic cells: beyond the necessity of T-cell help

21 January 2018

1 reference

B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors

21 January 2018

1 reference

Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002.

21 January 2018

1 reference

Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)

21 January 2018

1 reference

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes

21 January 2018

1 reference

Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.

21 January 2018

1 reference

How innate immune mechanisms contribute to antibody-enhanced viral infections

21 January 2018

1 reference

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

21 January 2018

1 reference

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

21 January 2018

1 reference

Fc receptor but not complement binding is important in antibody protection against HIV.

21 January 2018

1 reference

A requirement for FcγR in antibody-mediated bacterial toxin neutralization

21 January 2018

1 reference

Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma

21 January 2018

1 reference

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy

21 January 2018

1 reference

Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.

21 January 2018

1 reference

Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.

21 January 2018

1 reference

Mouse model recapitulating human Fcγ receptor structural and functional diversity

21 January 2018

1 reference

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

21 January 2018

1 reference

Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies

21 January 2018

1 reference

Interaction with FcγRIIB is critical for the agonistic activity of anti-CD40 monoclonal antibody.

21 January 2018

1 reference

An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells

21 January 2018

1 reference

A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodies

21 January 2018

1 reference

Antitumor activities of agonistic anti-TNFR antibodies require differential FcγRIIB coengagement in vivo

21 January 2018

1 reference

Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies

21 January 2018

1 reference

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

21 January 2018

1 reference

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

21 January 2018

1 reference

Novel roles for the IgG Fc glycan

21 January 2018

1 reference

Anti-inflammatory actions of intravenous immunoglobulin

21 January 2018

1 reference

Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura.

21 January 2018

1 reference

Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo

21 January 2018

1 reference

IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity

21 January 2018

1 reference

IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity.

21 January 2018

1 reference

Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

DC-SIGN gene promoter variants and IVIG treatment response in Kawasaki disease

21 January 2018

1 reference

A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

21 January 2018

1 reference

IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.

21 January 2018

1 reference

Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's)

21 January 2018

1 reference

SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis

21 January 2018

1 reference

12 December 2020

Fc gamma Rs modulate cytotoxicity of anti-Fas antibodies: implications for agonistic antibody-based therapeutics

1 reference

12 December 2020

Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity

1 reference

12 December 2020

FcγRIIb controls bone marrow plasma cell persistence and apoptosis

1 reference

12 December 2020

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene

1 reference

12 December 2020

NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic

1 reference

12 December 2020

Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants

1 reference

12 December 2020

Abnormal glycosylation of serum igg from patients with chronic inflammatory diseases

1 reference

12 December 2020

IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease

1 reference

12 December 2020

Basis of the intrinsic flexibility of the Cε3 domain of IgE

1 reference

12 December 2020

Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4

1 reference

12 December 2020

1 reference

12 December 2020

Killing some to make way for others

1 reference

12 December 2020

Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses

1 reference

12 December 2020

FcγRs in health and disease.

1 reference

12 December 2020

Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness

1 reference

12 December 2020

Identifiers

DOI

10.1038/NI.2939

1 reference

31 August 2017

1 reference